advertisement

Breast cancer

30 June 2011

Avastin for breast cancer rejected

An expert panel urged the US Food and Drug Administration to strip the Roche-made drug Avastin of its label for use against breast cancer because it is neither safe nor effective.

An expert panel urged the US Food and Drug Administration to strip the Roche-made drug Avastin of its label for use against breast cancer because it is neither safe nor effective.

A final decision by the FDA commissioner must be issued. The FDA does not have to follow the recommendations of the expert panel but it usually does.

 

Read Health24’s Comments Policy

Comment on this story
0 comments
Comments have been closed for this article.

Ask the Expert

Breast cancer expert

Dr Gudgeon qualified in Birmingham, England, in 1968. She has more than 40 years experience in oncology, and in 1994 she founded her practice, Cape Breast Care, where she treats benign and malignant breast cancers. Dr Boeddinghaus obtained her qualification at UCT Medical School in 1994 and her MRCP in London in 1998. She has worked extensively in the field of oncology and has a special interest in the hormonal management of breast cancer. She now works with Dr Gudgeon at Cape Breast Care. Read more.

Still have a question?

Get free advice from our panel of experts

The information provided does not constitute a diagnosis of your condition. You should consult a medical practitioner or other appropriate health care professional for a physical exmanication, diagnosis and formal advice. Health24 and the expert accept no responsibility or liability for any damage or personal harm you may suffer resulting from making use of this content.

* You must accept our condition

Forum Rules